APYX / Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates

Here is how Apyx Medical (APYX) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year. more_horizontal

Apyx Medical Corporation (NASDAQ:APYX ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Charles Goodwin - President & more_horizontal

Apyx Medical (APYX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of more_horizontal

Here is how Apyx Medical (APYX) and Haemonetics (HAE) have performed compared to their sector so far this year. more_horizontal

Apyx Medical Corporation (NASDAQ:APYX ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Charlie Goodwin - President & CE more_horizontal

Fintel reports that Archon Capital Management LLC has filed a 13G/A form with the SEC disclosing ownership of 3,452,030 shares of Apyx Medical Corp (A more_horizontal

Apyx Medical Corporation (NASDAQ:APYX ) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Charles Goodwin - President more_horizontal

The FDA has granted 510(k) clearance for Apyx Medical Corporation's (NASDAQ: APYX) Renuvion for subcutaneous dermatological and aesthetic procedur more_horizontal